James L Kennedy Selected Research

Brain-Derived Neurotrophic Factor (BDNF)

1/2022	Neurostructural correlates of BDNF rs6265 genotype in youth bipolar disorder.
1/2022	Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
1/2021	The Interplay Between Prenatal Adversity, Offspring Dopaminergic Genes, and Early Parenting on Toddler Attentional Function.
1/2019	BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
1/2018	Association study of BDNF and DRD3 genes with alcohol use disorder in Schizophrenia.
10/2017	Genetic epistasis regulates amyloid deposition in resilient aging.
11/2015	Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder.
4/2015	Meta-analysis and association of brain-derived neurotrophic factor (BDNF) gene with obsessive-compulsive disorder.
4/2015	Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.
1/2015	The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James L Kennedy Research Topics

Disease

134	Schizophrenia (Dementia Praecox) 04/2022 - 10/2002
43	Weight Gain 01/2020 - 10/2002
30	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2022 - 01/2002
30	Tardive Dyskinesia 01/2021 - 07/2002
27	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 09/2002
22	Psychotic Disorders (Schizoaffective Disorder) 10/2019 - 06/2003
19	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 08/2004
16	Mood Disorders (Mood Disorder) 01/2016 - 09/2002
15	Obesity 01/2020 - 04/2004
12	Mental Disorders (Mental Disorder) 01/2021 - 04/2004
7	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 05/2013
7	Movement Disorders (Movement Disorder) 01/2021 - 05/2009
7	Dyskinesias (Dyskinesia) 10/2020 - 11/2005
6	Birth Weight (Birth Weights) 01/2021 - 03/2015
6	Hyperphagia (Overeating) 01/2020 - 04/2008
6	Body Weight (Weight, Body) 08/2014 - 04/2004
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2009
5	Alcoholism (Alcohol Abuse) 01/2020 - 03/2010
4	Agranulocytosis (Granulocytopenia) 12/2021 - 04/2011
4	Treatment-Resistant Schizophrenia 12/2021 - 04/2011
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 05/2014
4	Gambling (Pathological Gambling) 01/2019 - 12/2007
4	Binge-Eating Disorder (Binge Eating Disorder) 05/2016 - 10/2007
4	Borderline Personality Disorder (Personality Disorders, Borderline) 02/2009 - 08/2006
4	Genetic Predisposition to Disease (Genetic Predisposition) 07/2007 - 01/2002
3	Drug-Related Side Effects and Adverse Reactions 12/2021 - 03/2002
3	Pain (Aches) 01/2021 - 01/2007
3	Neuroinflammatory Diseases 01/2021 - 03/2015
3	Inflammation (Inflammations) 01/2021 - 05/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 10/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 04/2012
3	Weight Loss (Weight Reduction) 03/2015 - 05/2010
3	Bulimia Nervosa 08/2014 - 01/2008
3	Food Addiction 01/2014 - 12/2011
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2021
2	Dementia (Dementias) 01/2022 - 04/2016
2	Cognitive Dysfunction 01/2022 - 01/2021
2	COVID-19 01/2022 - 09/2021

Drug/Important Bio-Agent (IBA)

85	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 07/2002
33	Clozapine (Clozaril)FDA LinkGeneric 12/2021 - 10/2002
31	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 03/2002
29	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 09/2002
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
15	Olanzapine (Zyprexa)FDA Link 10/2019 - 07/2009
14	Pharmaceutical PreparationsIBA 12/2021 - 05/2004
12	Antidepressive Agents (Antidepressants)IBA 04/2022 - 08/2007
12	Messenger RNA (mRNA)IBA 01/2020 - 07/2004
11	EnzymesIBA 01/2022 - 11/2005
11	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2002
10	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2011 - 12/2003
9	Serotonin (5 Hydroxytryptamine)IBA 02/2014 - 05/2004
8	Biological ProductsIBA 01/2021 - 06/2005
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2018 - 03/2004
8	Glutamic Acid (Glutamate)FDA Link 02/2017 - 08/2004
7	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 01/2003
7	Genetic Markers (Genetic Marker)IBA 01/2021 - 01/2002
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 04/2004
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2011 - 05/2003
5	gamma-Aminobutyric Acid (GABA)IBA 01/2014 - 01/2005
5	Serotonin ReceptorsIBA 03/2013 - 04/2004
5	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 02/2009 - 08/2004
4	Opioid Analgesics (Opioids)IBA 01/2022 - 06/2009
4	Glutamate Receptors (Glutamate Receptor)IBA 01/2022 - 05/2009
4	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2021 - 04/2010
4	Methylphenidate (Ritalin)FDA LinkGeneric 05/2016 - 10/2007
4	Monoamine Oxidase (MAO)IBA 01/2016 - 01/2007
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 10/2002
4	Haloperidol (Haldol)FDA LinkGeneric 03/2013 - 04/2010
4	Oxytocin (Pitocin)FDA LinkGeneric 03/2012 - 07/2010
4	Adrenergic Agents (Adrenergic Drugs)IBA 08/2011 - 04/2002
4	Nicotine FDA Link 07/2011 - 08/2004
4	Dopamine D3 ReceptorsIBA 06/2011 - 03/2002
4	3' Untranslated Regions (3' UTR)IBA 09/2006 - 05/2005
3	Mitochondrial DNA (mtDNA)IBA 07/2022 - 01/2018
3	MelatoninIBA 09/2021 - 11/2006
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2004
3	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2021 - 10/2002
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2020 - 01/2006
3	LipidsIBA 01/2019 - 09/2006
3	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2018 - 02/2004
3	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2017 - 12/2002
3	Nerve Growth Factors (Neurotrophins)IBA 01/2015 - 05/2008
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 03/2013
3	Aminobutyrates (Aminobutyric Acid)IBA 03/2014 - 12/2009
3	CalciumIBA 01/2014 - 01/2006
3	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 10/2012 - 07/2006
3	5-HT2C Serotonin ReceptorIBA 11/2010 - 11/2005
3	AntioxidantsIBA 12/2009 - 11/2005
3	Glutathione Peroxidase GPX1IBA 12/2009 - 09/2004
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2007 - 08/2004
3	Hormones (Hormone)IBA 10/2007 - 04/2004
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2007 - 10/2002
3	Protein Isoforms (Isoforms)IBA 12/2005 - 04/2005
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 05/2004 - 04/2002
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2021 - 09/2014

Therapy/Procedure

9	Therapeutics 09/2021 - 03/2002
5	Drug Therapy (Chemotherapy) 01/2018 - 03/2002
3	Precision Medicine 01/2021 - 09/2006
2	Polypharmacy 12/2021 - 02/2013